🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PTN
$PTN
🔒 US EquitiesPalatin Technologies Inc
AVG HISTORICAL GAP
-2.76%
MAX GAP RECORD
-8.30%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PTN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PTN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Sep 28, 2026 Earnings Release 2026-09-28 (BEFORE OPEN (07:00)) |
-2.38%
|
| May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN) |
-4.62%
|
| Feb 17, 2026 Earnings Release 2026-02-17 (BEFORE OPEN) |
+0.00%
|
| May 14, 2025 Earnings Release 2025-05-14 (BEFORE OPEN) |
+0.00%
|
| Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN) |
+3.03%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (BEFORE OPEN) |
-7.56%
|
| May 15, 2024 Earnings Release 2024-05-15 (BEFORE OPEN) |
-8.30%
|
| Feb 14, 2024 Earnings Release 2024-02-14 (AFTER CLOSE) |
-2.66%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.3%
Bullish Gaps (2)
Bearish Gaps (7)
Neutral / Flat (0)
📖 Intelligence Summary
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗